BP
HCA icon

Ballentine Partners’s HCA Healthcare HCA Stock Holding History

Ballentine Partners’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
3,670
-49
-1% -$20.7K 0.02% 293
2026
Q1 		$1.76M Buy
3,719
+21
+0.6% +$10.6K 0.02% 225
2025
Q4 		$1.73M Buy
3,698
+5
+0.1% +$2.32K 0.02% 218
2025
Q3 		$1.57M Buy
3,693
+29
+0.8% +$11.2K 0.02% 243
2025
Q2 		$1.4M Sell
3,664
-399
-10% -$144K 0.02% 262
2025
Q1 		$1.4M Sell
4,063
-6
-0.1% -$1.93K 0.02% 236
2024
Q4 		$1.22M Sell
4,069
-44
-1% -$15.4K 0.02% 246
2024
Q3 		$1.67M Buy
4,113
+107
+3% +$39.2K 0.03% 198
2024
Q2 		$1.29M Buy
4,006
+127
+3% +$41.3K 0.02% 219
2024
Q1 		$1.29M Buy
3,879
+38
+1% +$11.6K 0.02% 203
2023
Q4 		$1.04M Buy
3,841
+675
+21% +$167K 0.02% 223
2023
Q3 		$779K Sell
3,166
-18
-0.6% -$4.92K 0.02% 231
2023
Q2 		$966K Buy
3,184
+81
+3% +$22.5K 0.02% 201
2023
Q1 		$818K Buy
3,103
+124
+4% +$31.5K 0.02% 222
2022
Q4 		$715K Sell
2,979
-26
-0.9% -$5.82K 0.02% 225
2022
Q3 		$553K Buy
3,005
+439
+17% +$87.5K 0.02% 231
2022
Q2 		$431K Buy
2,566
+38
+2% +$8.16K 0.02% 260
2022
Q1 		$634K Buy
2,528
+51
+2% +$12.8K 0.02% 228
2021
Q4 		$637K Hold
2,477
– – 0.02% 236
2021
Q3 		$601K Buy
2,477
+18
+0.7% +$4.4K 0.02% 212
2021
Q2 		$508K Buy
2,459
+6
+0.2% +$1.22K 0.02% 231
2021
Q1 		$462K Sell
2,453
-118
-5% -$20.8K 0.02% 233
2020
Q4 		$423K Sell
2,571
-396
-13% -$57.9K 0.02% 235
2020
Q3 		$370K Buy
2,967
+390
+15% +$48.3K 0.02% 249
2020
Q2 		$250K Sell
2,577
-61
-2% -$6.34K 0.01% 310
2020
Q1 		$238K Buy
2,638
+144
+6% +$18.6K 0.01% 289
2019
Q4 		$368K Sell
2,494
-5
-0.2% -$671 0.02% 267
2019
Q3 		$301K Sell
2,499
-102
-4% -$13.2K 0.01% 291
2019
Q2 		$351K Buy
2,601
+1,004
+63% +$127K 0.02% 266
2019
Q1 		$209K Buy
+1,597
New +$214K 0.01% 305
2018
Q4 		– Sell
-1,603
Closed -$222K – 360
2018
Q3 		$222K Buy
+1,603
New +$200K 0.01% 317

Other funds holding HCA

MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SJL
Shayne & Jacobs LLC Nashville, Tennessee $337M AUM 19.04% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Ballentine Partners's HCA Position: Q2 2026 in Review

Ballentine Partners reduced its HCA Healthcare (HCA) stake by 1.3% in Q2 2026, selling an estimated $20.7K and leaving 3,670 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #293.

Ballentine Partners first reported a position in HCA in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.76M in Q1 2026. 185 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Ballentine Partners held 3,670 shares of HCA Healthcare worth $1.43M as of Q2 2026.
  • Ballentine Partners sold 49 HCA Healthcare shares in Q2 2026, an estimated $20.7K.
  • HCA Healthcare made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #293 holding.
  • Ballentine Partners first reported a position in HCA Healthcare in Q3 2018 and has held it in 31 quarters since.
  • Ballentine Partners's HCA Healthcare position peaked at $1.76M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.